ORZULTI

Details for Australian Trade Mark No. 1054344 (hide)

Owner Bristol-Myers Squibb Company a Delaware corporation

Convention US 13 DECEMBER 2004 78/531431

Service Spruson & Ferguson

Various Convention priority claimed: 13 December 2004, United States of America, No. 78/531431 in respect of PHARMACEUTICAL PREPARATIONS FOR HUMAN USE.

Filing Date 9 May 2005

Classes

Class 5 Pharmaceutical preparations for human use including pharmaceutical preparations for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants; diagnostic pharmaceutical preparations used to increase heart rate and contrast imaging agents

Event Publications

26 May 2005 Application filed

26 May 2005 Application Accepted

22 September 2005 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1054345-BLOOPLEBERRY

1054343-MULDORZA